IL112035A - רלוקסיפאן ותרכובות הקשורות לו כתכשירי רוקחות להגברת הליבידו בנשים לאחר בלות - Google Patents
רלוקסיפאן ותרכובות הקשורות לו כתכשירי רוקחות להגברת הליבידו בנשים לאחר בלותInfo
- Publication number
- IL112035A IL112035A IL11203594A IL11203594A IL112035A IL 112035 A IL112035 A IL 112035A IL 11203594 A IL11203594 A IL 11203594A IL 11203594 A IL11203594 A IL 11203594A IL 112035 A IL112035 A IL 112035A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- raloxifene
- increasing
- libido
- post
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/171,329 US5439931A (en) | 1993-12-21 | 1993-12-21 | Method for increasing libido in post-menopausal women |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL112035A0 IL112035A0 (en) | 1995-03-15 |
| IL112035A true IL112035A (he) | 1999-03-12 |
Family
ID=22623352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11203594A IL112035A (he) | 1993-12-21 | 1994-12-19 | רלוקסיפאן ותרכובות הקשורות לו כתכשירי רוקחות להגברת הליבידו בנשים לאחר בלות |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5439931A (he) |
| EP (1) | EP0659411B1 (he) |
| JP (1) | JPH07215865A (he) |
| KR (1) | KR950016724A (he) |
| CN (1) | CN1107705A (he) |
| AT (1) | ATE203405T1 (he) |
| AU (1) | AU690595B2 (he) |
| CA (1) | CA2138497A1 (he) |
| CZ (1) | CZ320594A3 (he) |
| DE (1) | DE69427806T2 (he) |
| DK (1) | DK0659411T3 (he) |
| ES (1) | ES2157960T3 (he) |
| GR (1) | GR3036983T3 (he) |
| HU (1) | HUT71477A (he) |
| IL (1) | IL112035A (he) |
| NO (1) | NO944925L (he) |
| NZ (1) | NZ270163A (he) |
| PT (1) | PT659411E (he) |
| RU (1) | RU94044321A (he) |
| SI (1) | SI0659411T1 (he) |
| ZA (1) | ZA9410094B (he) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5595722A (en) | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
| US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| CA2162586C (en) * | 1993-05-13 | 2006-01-03 | David J. Grainger | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| US6417198B1 (en) | 1993-12-21 | 2002-07-09 | Eli Lilly And Company | Methods of inhibiting CNS problems in post-menopausal women |
| EP0716854A3 (en) * | 1994-10-20 | 1996-08-28 | Lilly Co Eli | Compositions for inhibiting neuropeptide Y |
| US6562862B1 (en) * | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
| ZA982877B (en) * | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment of central nervous system disorders with selective estrogen receptor modulators. |
| WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| ATE301129T1 (de) | 1999-05-04 | 2005-08-15 | Strakan Int Ltd | Androgen glykoside und die androgenische aktivität davon |
| US20020013327A1 (en) * | 2000-04-18 | 2002-01-31 | Lee Andrew G. | Compositions and methods for treating female sexual dysfunction |
| WO2003070253A1 (en) * | 2002-02-21 | 2003-08-28 | Pantarhei Bioscience B.V. | Estrogenic component for treating decreased libido in women |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1993
- 1993-12-21 US US08/171,329 patent/US5439931A/en not_active Expired - Fee Related
-
1994
- 1994-12-19 NZ NZ270163A patent/NZ270163A/en unknown
- 1994-12-19 AT AT94309462T patent/ATE203405T1/de not_active IP Right Cessation
- 1994-12-19 CN CN94119742A patent/CN1107705A/zh active Pending
- 1994-12-19 HU HU9403661A patent/HUT71477A/hu unknown
- 1994-12-19 PT PT94309462T patent/PT659411E/pt unknown
- 1994-12-19 CZ CZ943205A patent/CZ320594A3/cs unknown
- 1994-12-19 ZA ZA9410094A patent/ZA9410094B/xx unknown
- 1994-12-19 NO NO944925A patent/NO944925L/no unknown
- 1994-12-19 ES ES94309462T patent/ES2157960T3/es not_active Expired - Lifetime
- 1994-12-19 JP JP6314588A patent/JPH07215865A/ja active Pending
- 1994-12-19 CA CA002138497A patent/CA2138497A1/en not_active Abandoned
- 1994-12-19 EP EP94309462A patent/EP0659411B1/en not_active Expired - Lifetime
- 1994-12-19 SI SI9430390T patent/SI0659411T1/xx unknown
- 1994-12-19 IL IL11203594A patent/IL112035A/he not_active IP Right Cessation
- 1994-12-19 DE DE69427806T patent/DE69427806T2/de not_active Expired - Fee Related
- 1994-12-19 DK DK94309462T patent/DK0659411T3/da active
- 1994-12-19 KR KR1019940034915A patent/KR950016724A/ko not_active Application Discontinuation
- 1994-12-19 AU AU81541/94A patent/AU690595B2/en not_active Ceased
- 1994-12-19 RU RU94044321/14A patent/RU94044321A/ru unknown
-
2001
- 2001-10-22 GR GR20010401853T patent/GR3036983T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU94044321A (ru) | 1996-10-20 |
| EP0659411B1 (en) | 2001-07-25 |
| ATE203405T1 (de) | 2001-08-15 |
| DK0659411T3 (da) | 2001-09-24 |
| ES2157960T3 (es) | 2001-09-01 |
| KR950016724A (ko) | 1995-07-20 |
| DE69427806D1 (de) | 2001-08-30 |
| CA2138497A1 (en) | 1995-06-22 |
| NO944925D0 (no) | 1994-12-19 |
| DE69427806T2 (de) | 2001-12-06 |
| AU690595B2 (en) | 1998-04-30 |
| ZA9410094B (en) | 1996-06-19 |
| PT659411E (pt) | 2001-11-30 |
| GR3036983T3 (en) | 2002-01-31 |
| HU9403661D0 (en) | 1995-02-28 |
| EP0659411A3 (en) | 1995-09-27 |
| NO944925L (no) | 1995-06-22 |
| SI0659411T1 (en) | 2001-12-31 |
| CZ320594A3 (en) | 1995-09-13 |
| CN1107705A (zh) | 1995-09-06 |
| HUT71477A (en) | 1995-11-28 |
| IL112035A0 (en) | 1995-03-15 |
| NZ270163A (en) | 1996-08-27 |
| AU8154194A (en) | 1995-06-29 |
| EP0659411A2 (en) | 1995-06-28 |
| JPH07215865A (ja) | 1995-08-15 |
| US5439931A (en) | 1995-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0652001B1 (en) | Methods for treating per-menopausal syndrome | |
| AU677700B2 (en) | Methods for inhibiting endometriosis | |
| EP0659411B1 (en) | Method for increasing libido in post-menopausal women | |
| AU691844B2 (en) | Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome | |
| IL111285A (he) | 2 - פניל - 3 - ארוילבנזותיופינים לשימוש כתורופות לעיכוב פיברוזה של האוטרוס | |
| EP0659413B1 (en) | Inhibition of CNS problems in post-menopausal women | |
| US5708010A (en) | Methods of inhibiting myeloperoxidase activity | |
| CA2138510A1 (en) | Methods of inhibiting dysfunctional uterine bleeding | |
| US5593987A (en) | Methods of inhibiting breast disorders | |
| US5578614A (en) | Methods for inhibiting weight gain or inducing weight loss | |
| CA2138507A1 (en) | Methods of inhibiting sexual precocity | |
| EP0769945B1 (en) | Use of 2-phenyl-3-aroylbenzothiophene derivatives for the manufacture of a medicament for bone healing and fracture repair | |
| JPH10504577A (ja) | 神経損傷を抑制する方法 | |
| US5494929A (en) | Methods of inhibiting growth hormone effects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |